HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

L Zabaglo, O Stoss, J Ruschoff, D Zielinski, J Salter, M Arfi, Ian Bradbury, U Dafni, M Piccart-Gebhart, M Procter, M Dowsett

    Research output: Contribution to journalArticle

    17 Citations (Scopus)
    LanguageEnglish
    Pages2761-2766
    JournalAnnals of Oncology
    Volume24
    Issue number11
    DOIs
    Publication statusPublished - 2013

    Cite this

    Zabaglo, L ; Stoss, O ; Ruschoff, J ; Zielinski, D ; Salter, J ; Arfi, M ; Bradbury, Ian ; Dafni, U ; Piccart-Gebhart, M ; Procter, M ; Dowsett, M. / HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab. In: Annals of Oncology. 2013 ; Vol. 24, No. 11. pp. 2761-2766.
    @article{dd57fa548d0342d7ab904694148a7e25,
    title = "HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab",
    author = "L Zabaglo and O Stoss and J Ruschoff and D Zielinski and J Salter and M Arfi and Ian Bradbury and U Dafni and M Piccart-Gebhart and M Procter and M Dowsett",
    year = "2013",
    doi = "10.1093/annonc/mdt275",
    language = "English",
    volume = "24",
    pages = "2761--2766",
    journal = "Annals of Oncology",
    issn = "0923-7534",
    number = "11",

    }

    Zabaglo, L, Stoss, O, Ruschoff, J, Zielinski, D, Salter, J, Arfi, M, Bradbury, I, Dafni, U, Piccart-Gebhart, M, Procter, M & Dowsett, M 2013, 'HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab', Annals of Oncology, vol. 24, no. 11, pp. 2761-2766. https://doi.org/10.1093/annonc/mdt275

    HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab. / Zabaglo, L; Stoss, O; Ruschoff, J; Zielinski, D; Salter, J; Arfi, M; Bradbury, Ian; Dafni, U; Piccart-Gebhart, M; Procter, M; Dowsett, M.

    In: Annals of Oncology, Vol. 24, No. 11, 2013, p. 2761-2766.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

    AU - Zabaglo, L

    AU - Stoss, O

    AU - Ruschoff, J

    AU - Zielinski, D

    AU - Salter, J

    AU - Arfi, M

    AU - Bradbury, Ian

    AU - Dafni, U

    AU - Piccart-Gebhart, M

    AU - Procter, M

    AU - Dowsett, M

    PY - 2013

    Y1 - 2013

    U2 - 10.1093/annonc/mdt275

    DO - 10.1093/annonc/mdt275

    M3 - Article

    VL - 24

    SP - 2761

    EP - 2766

    JO - Annals of Oncology

    T2 - Annals of Oncology

    JF - Annals of Oncology

    SN - 0923-7534

    IS - 11

    ER -